Integra LifeSciences Reports First Quarter 2024 Financial Results [Yahoo! Finance]
Integra LifeSciences Holdings Corporation (IART)
Last integra lifesciences holdings corporation earnings: 2/19 06:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.integralife.com
Company Research
Source: Yahoo! Finance
company, today reported financial results for the first quarter ending March 31, 2024. First Quarter 2024 Highlights First quarter revenues of $368.9 million declined 3.1% on a reported basis and declined 2.5% on an organic basis compared to the prior year. Revenue increased 1.6% on an organic basis excluding Boston First quarter GAAP earnings per diluted share of $(0.04), compared to $0.29 in the prior year; adjusted earnings per diluted share of $0.55, compared to $0.74 in the prior year Completed the acquisition of the Acclarent, Inc. on April 1 Updating full-year 2024 revenue guidance to a range of $1.672 billion to $1.687 billion from a range of $1.603 billion to $1.618 billion to include the close of the Acclarent acquisition, adding approximately $80 million to guidance, and updated expectations for the relaunch of SurgiMend® and PriMatrix®. "We are pleased with our strong first quarter financial performance, which reflects the strength of our diversified portfolio
Show less
Read more
Impact Snapshot
Event Time:
IART
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IART alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IART alerts
High impacting Integra LifeSciences Holdings Corporation news events
Weekly update
A roundup of the hottest topics
IART
News
- Global Wound Debridement Products Market is Expected to Grow at a CAGR of 6.6% over the Forecast Period (2024 – 2034): A Report by The Niche Research [Yahoo! Finance]Yahoo! Finance
- Integra LifeSciences Holdings Co. (NASDAQ: IART) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
- Integra LifeSciences to Present at the 2024 Bank of America Healthcare ConferenceGlobeNewswire
- Deciphering Integra (IART) International Revenue Trends [Yahoo! Finance]Yahoo! Finance
- Integra LifeSciences Holdings Co. (NASDAQ: IART) had its price target lowered by analysts at Morgan Stanley from $37.00 to $24.00. They now have an "underweight" rating on the stock.MarketBeat
IART
Earnings
- 5/6/24 - In-Line
IART
Sec Filings
- 5/17/24 - Form 8-K
- 5/13/24 - Form 4
- 5/13/24 - Form 4
- IART's page on the SEC website